BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (see an example) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below. Some articles will have been accepted based in part or entirely on reviews undertaken for other BMJ Group journals. These will be reproduced where possible.
Introduction
Is there evidence of iron supplementation and risk of infection specific to pregnancy -references are not specific to pregnancy .
Background information on settings and location of the trial.
Information is missing regarding:
• Malaria transmission intensity/seasonality • Use of anti-malarial prophylaxis • Routine practice regarding testing of haemoglobin at ante-natal clinics • Use of ARVS by women who were HIV-positive in and outside of the trial environment • Routine HIV testing at clinics Nawaru article needs to be submitted as a supporting document.
Sample size
It is not clearly described what criteria were used to determine the final sample size. 2,000 women in each group provided what power for each of the primary outcomes?. Was the 2,000 determine to include a proportion for incomplete data/loss to follow up. What baseline estimates were used and their sources for pre-term delivery and low birthweight? Consider including the different assumptions in a supplementary table.
Intervention
• Why was 400ug of folic acid given compared to 1mg folic acid in the two groups?
• Were the tablets combined iron and folate or separate?
Determination of outcomes
Can more information be provided regarding how health centres measured gestation and birth weight at delivery. It is not reported if there were any trial-related efforts to change normal practice in these centres, although it would appear that there was not. This is relevant because it will affect the precision of the measures and therefore how likely relatively small effects may be observed.
Statistical analysis
No mention is made in the description of the statistical analyses or in the results of the gestational ages at the different clinic visits and therefore the time periods between them. Although there were similar proportions of women attending the clinic once, twice, thrice etc, I suggest that the mean gestational ages at baseline and subsequent clinic visits should be included in Figure 1 .
RESULTS & CONCLUSIONS Results
Mean gestational age at recruitment is reported in Table 1 to be around 10 weeks for all groups. The exclusion criteria stated on p7 includes gestational age less than 12 weeks. How is this conflict accounted for?
Discussion
To provide context and assess the relative advantages and disadvantages of the two treatments, it would be useful to know the relative effects on haemoglobin at delivery. Is this information available? If so, it can and probably should be the subject of a different report, but worth mentioning its relevance here.
Do the results answer the research questions?
As the authors acknowledge, there is significant incomplete data. Although I understand the pressure to publish, it is not clear why the report should not wait until the much talked about further data are available. If the authors do not expect them to make any material difference, perhaps a sensitivity analysis could be included of different scenarios of the missing data? Tables and Figures  Table 1 .
• Needs consistent labelling and inclusion of percentages The general reader might be not familiar with the Mozambique primary care health system and so not be clear about whether the participants derived from the general population and whether the findings are, therefore, generalisable. Nwaru's does describe the health system but it would be useful for this paper to say that any pregnant woman is eligible for prenatal care and therefore could be recruited into the study. Are the methods adequately described?
The description of Interventions could do with reformulating. It appears to have been largely copied from Nwaru's paper with some loss and no improvements in clarity. For the Routine group the fact that the monthly supply was received over the whole period of pregnancy and at which points should be stated. The more complex intervention for the Selective group needs rewording to clarify how many tablets of each kind were given at each prenatal visit. As currently formulated, it is it is possible to understand the nature of the interventions, but only by expecting to make the reader make intelligent deductions. Are the statistical methods described?
Were the risk ratios (in Table 4 ) adjusted for any baseline information? RESULTS & CONCLUSIONS The paper contains delivery outcomes, which were available for only just over half of the sample, and Table 1 demonstrates that the groups with available information were similar to those without. As the main purpose of this research is treating anaemia, however, it would be appropriate to present the levels of haemoglobin for the Selective group (as done in Nwaru's paper) but separately for the groups with and those without delivery data. According to Nwaru's paper there were only 32% of women in the Selective group who needed iron treatment at recruitment. As the groups appeared to have similar profiles, one might expect the same proportion to have anaemia in Routine group. Does this mean that about two thirds of women from Routine group might not have needed iron tables and that excessive levels of iron might have affected the outcomes? It would be interesting to have the authors' comments on this in the discussion.
VERSION 1 -AUTHOR RESPONSE
Reviewer: Sharon Cox COMMENT 1. The conclusion is stated as "routine treatment did not confer advantages over screening and treatment for anaemia regarding maternal and child health". However the emphasis given in this statement is rather different to that given in the justification for the trial provided in the introduction, which emphasises the possible risk of routine supplementation. No mention is made of what possible advantages there may be for routine supplementation compared to screening for anaemia. For example, that anemia is the end-stage of iron deficiency and screening for anaemia will therefore miss a proportion of iron deficient women and also fail to prevent iron deficiency. Finally, routine iron supplementation is more often used for pragmatic reasons than for assumed health benefits.
RESPONSE
We have now modified the Introduction section of the paper to make our purpose clearer. In our justification for the trial, with think that our statements are rather neutral with regards to the effects of routine iron prophylaxis, not emphasizing its benefits or harms. We have now added a sentence on feasibility into the end of the paper (Conclusions section).
COMMENT 2.Introduction. Is there evidence of iron supplementation and risk of infection specific to pregnancyreferences are not specific to pregnancy .
We have now modified the sentence to indicate that most information on the relation between iron and infections come from non-pregnant population (page 5).
COMMENT 3.Background information on settings and location of the trial. Information is missing regarding:
3a Malaria transmission intensity/seasonality.
We have now provided the information on malaria situation of the study setting in the last part of section on Study design and population (pages 6-7).
COMMENT 3b Use of anti-malarial prophylaxis
We have now added information on this in the last part of section on Study design and population (pages 6-7).
COMMENT 3c Routine practice regarding testing of haemoglobin at ante-natal clinics
COMMENT 3d Use of ARVS by women who were HIV-positive in and outside of the trial environment
We have now added information on this in the last part of section on Study design and population (page 7).
COMMENT 3e Routine HIV testing at clinics
We have now added information on this in the last part of section on Study design and population (pages 6-7). 
We have now expanded the description of estimating sample size (pages 8-9).
COMMENT 5.Intervention.5a Why was 400ug of folic acid given compared to 1mg folic acid in the two groups?
The routine iron group received iron 60 mg and folic acid 400 μg combination in one tablet, while the selective iron group received, depending on the hemoglobin levels, 1 mg folic acid. The rationale for 1 mg folic acid in selective group was that pure folic acid was not licensed in Mozambique in 400 μg. This information is now added to the Interventions section of the paper (pages 9-10).
COMMENT 5b Were the tablets combined iron and folate or separate?
The iron and folic acids tablets were combined tablets for the routine group. This information is now added to the Interventions section of the paper (pages 9-10).
COMMENT 6. Determination of outcomes. Can more information be provided regarding how health centres measured gestation and birth weight at delivery. It is not reported if there were any trial-related efforts to change normal practice in these centres, although it would appear that there was not. This is relevant because it will affect the precision of the measures and therefore how likely relatively small effects may be observed.
We have now indicated from which kind of data source the main outcome measures came. Gestational age at birth was most complicated as we used several sources to determine it (please see the section on Data collection and follow-up, pages 10.). The measurement of the outcomes was done as routine and no changes were made as a result of the trial.
COMMENT 7. Statistical analysis. No mention is made in the description of the statistical analyses or in the results of the gestational ages at the different clinic visits and therefore the time periods between them. Although there were similar proportions of women attending the clinic once, twice, thrice etc, I suggest that the mean gestational ages at baseline and subsequent clinic visits should be included in Figure 1 .
We have now included this information in Figure 1 COMMENT 8. Results. Mean gestational age at recruitment is reported in Table 1 to be around 10 weeks for all groups. The exclusion criteria stated on p7 includes gestational age less than 12 weeks. How is this conflict accounted for?
Thank you for this important comment. We have now rectified the problem with our calculation of the gestational age at recruitment and corrected the figures in Table 1 and Figure 1 .
COMMENT 9. Discussion. To provide context and assess the relative advantages and disadvantages of the two treatments, it would be useful to know the relative effects on haemoglobin at delivery. Is this information available? If so, it can and probably should be the subject of a different report, but worth mentioning its relevance here.
We do not have information of hemoglobin at delivery. (It is not customary to meaure it in birth hospitals/ health centers) COMMENT 10. Do the results answer the research questions? As the authors acknowledge, there is significant incomplete data. Although I understand the pressure to publish, it is not clear why the report should not wait until the much talked about further data are available. If the authors do not expect them to make any material difference, perhaps a sensitivity analysis could be included of different scenarios of the missing data?
The reason to write this paper is not due to pressure to publish (i.e. to get publications), but to contribute to the current debate of the need of iron prophylaxis. As we argued there is very little data on this in malaria areas, and other researchers may be interested in our preliminary birth results. The final results will be much delayed due to problems we could not anticipate in the planning stage of the project). Furthermore, this paper reports the final results on pregnancy outcomes.
COMMENT 11. Tables and Figures. 11a Table 1 . Needs consistent labelling and inclusion of percentages
We have now revised the tables to be consistent with the Figure. Percentages are now presented as part of the labeling for Table 1. COMMENT 11b. Table 2 .Typo in the p-value for Duration of gestation? Currently reads 0.056!?
The p-value for the difference between the iron groups in gestational age at birth (p=0.056) is correct, not a typo.
Reviewer: Yana Vinogradova COMMENT 1. Are the patients representative...? The general reader might be not familiar with the Mozambique primary care health system and so not be clear about whether the participants derived from the general population and whether the findings are, therefore, generalisable. Nwaru's does describe the health system but it would be useful for this paper to say that any pregnant woman is eligible for prenatal care and therefore could be recruited into the study.
We have now added a statement to describe this in the section, Study design and population (pages 6-7).
COMMENT 2a. Are the methods adequately described? The description of Interventions could do with reformulating. It appears to have been largely copied from Nwaru's paper with some loss and no improvements in clarity.
We have now modified several sections of the methods part of the paper to make it clearer (see also our responses to Sharon Cox's comments).
COMMENT 2b. For the Routine group the fact that the monthly supply was received over the whole period of pregnancy and at which points should be stated.
This has now been added in the Interventions section of the paper (pages 9-10).
COMMENT 2c. The more complex intervention for the Selective group needs rewording to clarify how many tablets of each kind were given at each prenatal visit. As currently formulated, it is it is possible to understand the nature of the interventions, but only by expecting to make the reader make intelligent deductions.
The description of the intervention for the Selective group has now been revised (see the Interventions, pages 9-10) section.
COMMENT 3. Are the statistical methods described? Were the risk ratios (in Table 4 ) adjusted for any baseline information? RESPONSE They were not (as the baseline was similar in the two groups). This has now been added as a footnote to Table 4. COMMENT 4. The paper contains delivery outcomes, which were available for only just over half of the sample, and Table 1 demonstrates that the groups with available information were similar to those without. As the main purpose of this research is treating anaemia, however, it would be appropriate to present the levels of haemoglobin for the Selective group (as done in Nwaru's paper) but separately for the groups with and those without delivery data.
We have now added the variable (hemoglobin at recruitment in the selective group) to Table 1 , and commented it in the Results section of the paper (page 13).
COMMENT 5. According to Nwaru's paper there were only 32% of women in the Selective group who needed iron treatment at recruitment. As the groups appeared to have similar profiles, one might expect the same proportion to have anaemia in Routine group. Does this mean that about two thirds of women from Routine group might not have needed iron tables and that excessive levels of iron might have affected the outcomes? It would be interesting to have the authors' comments on this in the discussion.
The definition of anemia in Maputo context is difficult because it is not known what hemoglobin level is actually anemic. We used the <9 g/dL Hb cut-off while others have used other figures. Our cut-off was based on agreement with local researchers. We do not know at what level overload starts. We did not measure iron levels but only hemoglobin, and hemoglobin does not directly measure iron level in the body. Consequently, in the discussion of our results we have not gone into the potential mechanisms of the effect of prophylactic iron. 
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